Miller Class III multiple gingival recessions Oral Health
Conditions
Interventions
The test group will be treated with apical buccal access approach and connective tissue graft
Control group will be treated with tunnel approach and connective tissue graft
The intervention will we
Sponsors
ThinkingPerio Research
Eligibility
Sex/Gender
All
Age
18 Years to 120 Years
Inclusion criteria
Inclusion criteria: 1. Informed consent after detailed information 2. Adults at least 18 years of age 3. Patients with multiple recessions (=2 teeth) class III Miller with shallow vestibulum depth and keratinized mucosa 4. Non-molar teeth 5. Upper and lower jaw 6. Healthy or periodontally treated patients 7. Systematically healthy or with fully controlled or stabilized diseases 8. A medical report will be requested to confirm the stabilization of the specific disease 9. General plaque control (FMPS) =25%
Exclusion criteria
Exclusion criteria: 1. Pregnant or breastfeeding patients 2. Uncontrolled periodontal disease 3. Patients treated with any medication that affects gingival conditions such as causing hyperplasia 4. Alcohol and/or drug abuse 5. Not signing informed consent 6. Molar area
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Recession reduction measured by a manual periodontal probe and intraoral scanning at baseline, 6 months and 12 month | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. Complete root coverage measured by a manual periodontal probe and intraoral scanning at baseline, 6 months and 12 months 2. Increased vestibule depth measured by a manual periodontal probe and intraoral scanning at baseline, 6 months and 12 months 3. Keratinized gum augmentation measured by a manual periodontal probe and intraoral scanning at baseline, 6 months and 12 months 4. Volume increase measured by a manual periodontal probe and intraoral scanning at baseline, 6 months and 12 months 5. Time spent on both types of procedures measured in minutes intrasurgically 6. Patient satisfaction with the treatment received and its relationship with pre-surgical expectations measured by a Visual Analogue Scale at baseline, 2weeks, 4weeks, 12weeks, 6months and 12 months 7. Analgesia intake measured taking into account the number of analgesic pills consumption by patient self-report at baseline, 6 months and 12 months 8. Aesthetic satisfaction by the clinical examiner measured by a blinded examiner at 6 and 12 months in order to evaluate the visual satisfaction with obtained outcome | — |
Countries
Spain
Contacts
Public ContactErik;Alberto Regidor Correa;Ortiz-Vigón
;
Outcome results
None listed